Wingate Wealth Advisors Inc. Purchases Shares of 2,550 Henry Schein, Inc. (NASDAQ:HSIC)

Wingate Wealth Advisors Inc. purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,550 shares of the company’s stock, valued at approximately $176,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC grew its position in Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after buying an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP raised its stake in shares of Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after purchasing an additional 600,000 shares in the last quarter. Nuance Investments LLC lifted its position in Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after purchasing an additional 414,748 shares during the period. Clarkston Capital Partners LLC boosted its stake in Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after buying an additional 71,560 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Henry Schein by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock valued at $85,662,000 after buying an additional 6,184 shares during the period. Institutional investors own 96.62% of the company’s stock.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.14% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on HSIC shares. Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Barrington Research increased their price target on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Finally, Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Seven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $80.10.

Henry Schein Trading Down 1.1 %

HSIC stock opened at $79.00 on Monday. The business has a fifty day moving average of $73.70 and a 200-day moving average of $71.80. The company has a market cap of $9.85 billion, a P/E ratio of 32.51, a PEG ratio of 2.21 and a beta of 0.91. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.